Phaarmasia - Quaterly Results

12 Aug 2024 Evaluate
The Revenue for the quarter ended  June 2024 of Rs. 82.92 millions grew by 20.59 % from Rs. 68.76 millions.The Total Profit for the quarter ended June 2024 of Rs. 2.77 millions grew from Rs.-2.65 millions Operating profit Margin for the quarter ended June 2024 improved to 3.31% as compared to -1.76% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 82.92 68.76 20.59 82.92 68.76 20.59 305.93 274.90 11.29
Other Income 1.48 1.44 2.78 1.48 1.44 2.78 6.62 5.16 28.29
PBIDT 3.31 -1.76 -288.07 3.31 -1.76 -288.07 -1.58 -10.26 -84.60
Interest 0.03 0.08 -62.50 0.03 0.08 -62.50 0.44 0.45 -2.22
PBDT 3.28 -1.84 -278.26 3.28 -1.84 -278.26 -2.02 -10.71 -81.14
Depreciation 0.79 0.85 -7.06 0.79 0.85 -7.06 3.44 3.60 -4.44
PBT 2.49 -2.69 -192.57 2.49 -2.69 -192.57 -5.46 -14.31 -61.84
TAX -0.28 -0.04 600.00 -0.28 -0.04 600.00 -0.28 -1.73 -83.82
Deferred Tax -0.28 -0.04 600.00 -0.28 -0.04 600.00 -0.28 -1.73 -83.82
PAT 2.77 -2.65 -204.53 2.77 -2.65 -204.53 -5.18 -12.58 -58.82
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) 3.99 -2.56 -255.95 3.99 -2.56 -255.95 -0.52 -3.73 -86.16

Phaarmasia Share Price

106.25 -2.16 (-1.99%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×